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An extensive review of sarcoidosis in 1952. re­
ported that one of the characteristics of the disease 
is the unaffected joints ( 8). However, a careful 
reading of this article reveals gross photographs and 
radiographs which are quite compatible with in­
flammatory arthritis. In that same year it was em­
phasized that sarcoidosis can present itself as ar­
thritis ( 10). The association of sarcoidosis with 
hilar adenopathy, erythema nodosum, and poly­
arthritis was described in 1953 (Lofgren's Syn­
drome) (7). Five cases of sarcoid arthritis were 
reported by Sokoloff and Bunim in 1959, and 
synovial granulomata were noted in three of the 
five patients studied ( 12). Subsequently, a number 
of articles have appeared in the literature reporting 
the musculoskeletal involvement of sarcoidosis to 
vary between 2.2 and 38% (9, 13). Usually asso­
ciated with hilar adenopathy and erythema nodosum, 
musculoskeletal sarcoidosis is less frequently linked 
with transient arthritis, arthralgia, or periarticular 
inflammation. Its relationship to destructive poly­
arthritis, myopathy, or tendinitis is relatively un­
common. 
The discovery of the rheumatoid factor in 
sarcoidosis ( 6, 11), coupled with the observed 
musculoskeletal involvement, prompted a review of 
our experience at the Medical College of Virginia. 
The charts of 224 patients with sarcoidosis 
were examined. Of the 224, those selected for our 
study were at the time being followed as outpatients 
because of their condition. Sixty such patients were 
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available for personal observation and evaluation. 
These 60 patients had been followed at MCV from 
I to 372 months with an average of 46.8 months. 
In making a histologic diagnosis of sarcoidosis, 
we rely primarily on peripheral lymph nodes. 
Excised palpable cervical, epitrochlear, and axillary 
nodes have been our first choice for biopsy material. 
In the absence of palpable lymph nodes, we usually 
perform a scalene node biopsy, and in about 90% 
of these cases, non-caseating granulomata have been 
revealed when the clinical findings suggested sar­
coidosis. In a few patients, a skin lesion has been 
used as material for microscopic examination, but 
in most cases when the skin has been biopsied 
we have obtained a second source of material. 
A lung biopsy has been performed in about 5% 
of our patients; in most instances the clinical 
manifestations were atypical, and a lung biopsy was 
considered a better source of material for bac­
teriological as well as for histological studies. We 
generally have not relied on liver biopsies where the 
yield of granulomata is around 7 5 % ( I ) . 
The following serologic procedures were em­
ployed. 
I. Sensitized Sheep Cell (SSC): The SSC test 
used was the Heller ( 4) modification of 
the Waaler-Rose test. Test sera were ab­
sorbed with unsensitized sheep cells and 
diluted in saline. Sheep cells, from a con­
stant source, were sensitized with I /20 the 
basic agglutinin titer of rabbit anti-sheep 
cell serum. Titers of I : 20 and above were 
considered positive. The SSC test was 
standardized in this way in order to obtain 
relative specificity although it is not as 
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sensitive a test as those used in other lab­
oratories. 
2. Sensitized Human Cell (SHC): A selected 
DCe/DCe test cell was sensitized with Rip­
ley serum (high-titered anti-DC), diluted 
I : I 0. The Rh positive cells were sensitized 
for 30 minutes at 37 °C and then washed 
three times with saline. Test sera were 
titrated in saline in 0.1 ml volumes. Titers 
of I : 20 or above were considered positive. 
The SHC test was especially valuable in 
obtaining reproducible titers of rheumatoid 
factor in those individuals who were negative 
with the SSC test. 
3. Latex Test: This test was performed with 
the commercial reagents supplied by the 
Hyland Laboratories, Los Angeles, Cali­
fornia. Reactions with the sera diluted I : 20 
were considered positive. 
The results of our studies are illustrated in 
the accompanying tables. Table I lists the average 
age of the patients when sarcoidosis was first diag­
nosed. Of the 60 patients, 38 were Negro females 
(63.3% ). 
Table 2 lists the presenting symptoms or why 
a diagnosis of sarcoidosis was suspected. It is noted 
that 22 of the 60 patients (36.6%) were asympto­
matic, but sarcoidosis was suspected from screening 
chest radiographs and was subsequently proved . 
Table 3 lists the types of musculoskeletal in­
volvement present in 19 patients. Nine of the 60 
patients (IS%) presented with arthritis as the initial 
manifestation of sarcoidosis. Five of these nine had 
the syndrome of migratory arthritis, erythema nodo­
sum, and radiographic findings of hilar and right 
paratracheal lymphadenopathy. Two patients had 
arthritis and an abnormal chest radiograph but did 
not have erythema nodosum. One patient, a 20-ycar­
old white female, had the recently described condition 
of periarticular ankle inflammation and bilateral 
hilar adenopathy (2). The arthritis and pul­
monary radiographic findings cleared spontaneously 
w1thm four weeks in eight of these nine patients. 
One patient progressed to destructive polyarthritis 
TABLE I. AGE, RACE, AND SEX OF 60 PATIENTS WITH 
SARCOIDOSIS 
Ages: 
Av: 
NM 
9 
( 14-48) 
25 
* Only I patient over 52 
NF 
38 
(13-72*) 
28 
WM 
4 
(27-61) 
38 
WF 
9 
(24-50) 
35 
TABLE 2. PRESENTING SYMPTOMS OR WHY SARCOIOOSIS WAS 
SUSPECTED IN 60 PATIENTS 
No. 
I. Routine chest film 22 
2. Chronic cough 7 
3. Fever or undetermined origin 6 
4. Erythema nodosum and arthritis 
5. Uveitis 
6. Arthritis 4 
7. Lymphadenopathy 4 
8. Dyspnea 3 
9. Hoarseness 2 
10. Fatigue 2 
which spontaneously entered a permanent remission 
in two years. 
Six of the remaining ten patients (32% of 
total) developed short-lived arthralgia during their 
course of follow-up. Four of the six progressed 
from Stage I pulmonary disease (hilar lymphade­
nopathy) to Stage 2 disease (hilar lymphadenopathy 
and pulmonary infiltration). Two patients had Stage 
I pulmonary disease which became normal in six 
months. 
The other four patients ( 21 % of total) de­
veloped either short-lived oligo- or polyarthritis. 
Three of these patients progressed from Stage I to 
Stage 2 pulmonary disease. One patient progressed 
from Stage 2 to Stage 3 ( pulmonary infiltration and 
fibrosis). 
Other Organs Involved. Liver function studies, 
other than serum protein determinations, were not 
routinely performed. Liver biopsy was carried out 
TABLE 3. TYPES OF MUSCULOSKELETAL INVOLVEMENT 
PRESENT IN]!) OF 60 PATIENTS WITH SARCOIDOSIS 
I. Erythema nodosum, hilar adenopathy, arthritis 
II. 
I II. 
IV. 
V. 
Total: 
Total NM NF WM WF 
5 4 
Transient arthritis 
Total NM 
6 
Transient arthralgia 
Total NM 
6 
NF 
NF 
WM 
2 
WM 
Periart. inflam. and hil. adenopathy 
Total NM NF WM 
I 
Destructive polyarthritis 
Total NM NF WM 
I I 
0 11 * 4 
WF 
I 
WF 
WF 
WF 
4 
* The preponderance or Negro remales is in accord with 
the observations or others. 
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in only one patient, and this revealed non-caseating 
granulomata. Marked hepatomegaly was noted in 
three patients. Six patients had uveitis. One pa­
tient had uveoparotid fever and one asymptomatic 
parotid swelling. Laryngeal involvement in two 
patients was manifested by hoarseness, and one 
required a tracheostomy. Skin involvement of our 
patients could not be evaluated since careful skin 
examination was not performed at each visit. Only 
three patients, however, were noted to have skin 
involvement initially. 
Synovial Fluid. Synovial fluid examination was 
performed in only two patients. One patient was 
a 25-year-old Negro female who entered the hos­
pital because of fever of unknown origin. Poly­
arthritis subsequently developed. Synovial fluid ex­
amination revealed a poor mucin clot; leukocyte 
count of 24,700/mm3 with 87% polymorphonuclear 
cells and 13% mononuclear cells; sugar 30 mg per 
100 ml; and protein 4.2 gms per JOO ml. No crystals 
were observed. Percutaneous synovial biopsy re­
vealed a non-specific chronic synovitis. 
The other patient, a 30-year-old white male, had 
Lofgren's syndrome. The mucin clot test was poor; 
leukocyte count 42,500/mm'i with 90% polymor­
phonuclear cells and 10% mononuclear cells; and 
sugar 78 mg per 100 ml with simultaneous blood 
sugar of 102 mg per 100 ml. No crystals were ob­
served. Synovial fluid protein was not done. In 
neither of these fluids was rheumatoid factor found. 
Miscellaneous Blood Studies. Four of the 60 
patients had peripheral leukocyte counts of less than 
4,500/mm3. In none of these was there peripheral 
lymphadenopathy or splenomegaly. 
Serum calcium levels were determined in all 
60 patients. In only one case was there an elevated 
level-12.4 mg per 100 ml. 
Serum uric acid levels were performed in all 
19 of the patients with articular symptoms and in 
23 of the other patients. No elevations were found. 
Rheumatoid Factor and Serum Proteins. Re­
active slide latex flocculation tests with negative 
sensitized human cell tests were noted in only two 
of the 60 patients (3.3% ). One of these patients 
was a 32-year-old Negro female with Stage 3 lung 
disease ( pulmonary infiltration and fibrosis) of at 
least seven years' duration. Articular symptoms were 
denied. The serum gamma globulin was diffusely 
elevated. She was receiving long-term adrenocor­
ticosteroids. The other patient was a 30-year-old 
Negro female who had similar history and lab­
oratory findings. 
Serum protein electrophoresis was performed on 
47 of the 60 patients. An elevated gamma globulin 
of the diffuse type was noted in 35 (74%). 
Conclusion. Articular manifestations of sar­
coidosis were present in 19 of our 60 patients 
( 32 % ) . This correlates with previously reported 
studies. In all of our cases but one, the articular 
manifestations subsided in eight weeks. This fact 
and the absence of hyperuricemia are in contra­
distinction to other studies for which we have no 
adequate explanation ( 13, 5, 3). 
The finding of reactive latex flocculation tests 
in only two of 60 patients is an interesting observa­
tion and deserves further comment. 
It has become apparent that rheumatoid factors 
are not abnormal antibodies but rather normal serum 
components present in low titer in normal as well 
as diseased persons. These "heterophile" anti­
globulin antibodies reach their highest titers in 
rheumatoid arthritis, and the diagnostic value of 
high titers of these antibodies may be compared 
with the diagnostic value of titers of another het­
erophile, the anti-sheep erythrocyte antibody and 
the associated disease, infectious mononucleosis. 
Positive slide latex tests have very little diag­
nostic value except possibly in the negative sense. 
The percentage of positive tests in a non-rheumatic 
population is apparently related to the degree of 
hypergammaglobulinemia. 
In our geographic area, the young Negro fe­
male, in accordance with our study, was most prone 
to sarcoidosis. This segment of the population is 
not characterized by an unusually high incidence 
of positive latex tests, and thus we were not sur­
prised to find that our patients with sarcoidosis did 
not show an increased incidence of positive tests 
for rheumatoid factor. None of these patients showed 
positive SHC or SSC tests. 
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